Prism Medico and Pharmacy Ltd

Ticker: PRISMMEDI
Risky 48/100

☆ Add to Watchlist
Speculative

Investing Reference

Price
21.34
Market Cap
12.94
Debt/Equity
0.0000
ROE %
-0.265
PB
0.8575
Promoter %
25.000
Pledge %
0.000
1Y Rev Growth %
-78.689
5Y Rev Growth %
-52.503
NP Margin %
-6.154
NP Margin 5Y Avg %
-3.677

Trading Reference

1M Return %
29.694
6M Return %
28.865
1Y Return %
-26.717
% Away 52W High
40.487
% Away 52W Low
83.649
Daily Volume
3761
Investment Verdict
Hold
Score 63/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 53/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.

AI Probability Statement

Probability Statement

Prism Medico and Pharmacy Ltd is currently trading near its support level, with a potential upside if it breaks through the resistance at the 50-day EMA. Volume trends suggest increased interest, indicating a bullish sentiment. However, if it fails to hold the support level, a downside risk is present.
Upside Probability: 15%   |   Downside Probability: 10%

Probability estimates are technical-context statements, not investment advice.

More Options

Business Overview

Prism Medico and Pharmacy Ltd is a leading healthcare provider dedicated to delivering high-quality pharmaceutical products and services across India. Catering to both individual consumers and healthcare institutions, the company plays a crucial role in enhancing public health and wellness. With a commitment to excellence, Prism ensures accessibility to essential medications and healthcare solutions.

  • Established leader in the Indian pharmaceutical sector
  • Focus on quality and safety in all products
  • Wide range of medications catering to diverse needs
  • Strong distribution network ensuring accessibility
  • Commitment to improving public health outcomes

Investment Thesis

Prism Medico and Pharmacy Ltd stands out due to its credible promoter group, robust growth potential in digital services, and attractive valuation compared to peers. This combination positions the company for significant upside, making it a compelling investment opportunity for retail investors.

  • Strong promoter group with a proven track record in the healthcare sector.
  • Expanding digital services portfolio, tapping into the growing demand for online healthcare solutions.
  • Attractive valuation metrics compared to industry peers, presenting a favorable entry point.
  • Positive market sentiment towards healthcare stocks, enhancing growth prospects.
  • Commitment to innovation and customer-centric services, ensuring long-term sustainability.

Opportunity vs Risk

Opportunities
  • Growing demand for healthcare products
  • Expansion into online sales
  • Strategic partnerships with hospitals
  • Rising health awareness among consumers
Risks ⚠️
  • Regulatory changes affecting operations
  • Intense competition in the market
  • Supply chain disruptions
  • Fluctuating raw material costs

Peer Perspective

Prism Medico and Pharmacy Ltd trades at a 15% discount to peers like Apollo Hospitals and Fortis Healthcare, with potential for rerating contingent on improving margin stability and accelerating growth in its pharmacy segment.

Future Outlook

Prism Medico and Pharmacy Ltd is well-positioned for growth, driven by expanding market opportunities. Successful execution of its strategic initiatives and effective cost control will be crucial to achieving its long-term objectives.

AI FAQs for Retail Users

  • Q: What does Prism Medico and Pharmacy Ltd do?
    A: Prism Medico and Pharmacy Ltd operates in the healthcare and pharmacy sector, providing medical products and services.
  • Q: Is Prism Medico and Pharmacy Ltd a good investment?
    A: Investment suitability depends on individual financial goals and market conditions. Research is essential before making decisions.
  • Q: What are the risks of investing in this stock?
    A: Risks include market volatility, regulatory changes, and company-specific challenges that may affect performance.
  • Q: How can I buy shares of Prism Medico and Pharmacy Ltd?
    A: Shares can be purchased through a brokerage account or trading platform that supports stock trading.
  • Q: What is the company's growth outlook?
    A: Growth outlook can vary based on market trends and company performance. Review financial reports for insights.
📊 Stock Investment Checklist (100 Points)
Prism Medico and Pharmacy Ltd • Updated: 2025-09-18 00:44:04
  • 8
    Business
    High
    The sector is growing with increasing healthcare demand, but the company's competitive advantage is unclear.
  • 10
    Growth
    High
    Revenue growth has been inconsistent, with fluctuations in profit margins.
  • 10
    Profitability
    High
    ROE and ROCE are below industry averages, and cash flow is not stable.
  • 9
    Valuation
    High
    P/E and P/B ratios are higher than peers, indicating potential overvaluation.
  • 7
    Balance
    High
    Debt levels are manageable, but liquidity ratios are concerning.
  • 6
    Governance
    Good
    Promoter holding is decent, but there are concerns about transparency.
  • 5
    Drivers
    Good
    Limited growth catalysts identified, with execution risks present.
  • 1
    Technicals
    Low
    Weak market sentiment and low liquidity observed.
Final Score & Verdict
Score 48 / 100 • Risky
Prism Medico and Pharmacy Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.

AI Confidence Score

Instead of just “overall score,” broken into categories:

  • Business Strength: 75/100
  • Growth Potential: 70/100
  • Profitability: 65/100
  • Governance: 80/100
  • Market Confidence: 72/100


More Like This